Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Individualised dosing of commonly used anti-cancer agents

Pharmacogenomics guided adaptive dosing of fluoropyrimidines


30 Sep 2019


Individualised dosing of commonly used anti-cancer agents


Cancer Prevention;  Cytotoxic Therapy;  Clinical Research

Tumour Site


Hans Gelderblom


H. Gelderblom

Author affiliations

  • Medical Oncology Dept, Leids Universitair Medisch Centrum (LUMC), 2333 ZA - Leiden/NL


Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.